Neurointervention is a medical specialty that utilizes minimally invasive endovascular surgical techniques and image-guided procedures to diagnose and treat various neurological disorders. Trained as neurologists with additional expertise in vascular and endovascular surgery, interventional neurologists are able to access the brain and spinal cord through small skin punctures rather than traditional open surgery. Some of the common conditions managed with interventional techniques include aneurysms, strokes, spinal stenosis and arteriovenous malformations (AVMs).
Endovascular Treatment of Brain Aneurysms
One of the primary applications of Interventional Neurology is in the treatment of brain aneurysms. A brain aneurysm is a weak or thin spot on a brain artery that balloons out and fills with blood. As these develop silently over time, aneurysms can rupture suddenly causing a devastating subarachnoid hemorrhage or stroke.
Traditionally, brain aneurysms were surgically clipped to prevent bursting. However, endovascular coiling has emerged as a less invasive option. Using advanced imaging like 3D catheter angiography, interventional neurology specialists are able to thread microscopic catheters and guidewires through blood vessels in the groin or arm all the way up to the brain aneurysm. There, platinum coils are deployed into the aneurysm in order to occlude or block it off from circulation over time. Patients recover faster with endovascular coiling and have fewer complications compared to open craniotomy. It is now the preferred first-line treatment for many aneurysms.
Mechanical Thrombectomy for Acute Stroke
In the case of an acute ischemic stroke caused by a large vessel occlusion in the brain, rapid restoration of blood flow is critical to limiting neurological injury. Previously, intravenous thrombolysis (clot-busting drugs) were the only FDA approved treatment if given within 4.5 hours of onset. However, endovascular thrombectomy using mechanical devices has transformed stroke care by directly removing the clot.
Using navigational techniques, interventional neurology specialists access the blocked vessel with a catheter. Microcatheters and retrievers are advanced past the clot where special stents or scaffolds capture and extract the thrombosis. These groundbreaking techniques have been shown to nearly double functional independence in stroke patients when performed within 6 hours of symptoms compared to pharmaceutical treatments alone. As a result, most major hospitals now have rapid access to stroke specialists and neurointerventional suites round-the-clock.
Peripheral Endovascular Treatments
In addition to cranial interventions, interventional neurology specialists also employ endovascular techniques to treat various spinal and peripheral nerve disorders. For example, balloon angioplasty and stent placement helps open up narrowed or obstructed blood vessels in the neck and spine, known as carotid or vertebral artery stenosis, which can cause debilitating strokes. Similarly, transluminal angioplasty and stenting is used for compression of the spinal cord from spur bone overgrowth (spinal stenosis), restoring nerve function without open decompressive surgery.
Other Targeted Applications
Aside from cerebral aneurysms and arterial occlusions, interventional approaches have expanded treatment options for many other brain conditions as well. Ablative procedures using laser, radiofrequency or ethanol can precisely target epileptic foci or tumors deep within the brain that are not easily accessible by traditional surgical resection. Furthermore, advanced embolization techniques allow obliteration of dangerous vascular abnormalities such as arteriovenous malformations and dural fistulas that cause intracranial hemorrhage risk.
Future Directions and Innovation
Rapid technological innovation continues driving expansion of Interventional Neurology. New mechanical thrombectomy devices constantly strive to achieve faster, simpler and more complete clot removal. Improved microcatheters and guidewires push the boundaries of navigating tortuous cerebral anatomy. Expanding diagnostic capabilities like high resolution digital subtraction angiography and high field MRI/CT fusion provide exquisite real-time visualization. Combination treatments merge catheter-based strategies with pharmacological innovations to maximize effectiveness.
Most importantly, numerous clinical trials demonstrate improved outcomes and cost-effectiveness for many conditions treated by minimally invasive endovascular techniques compared to other surgical or medical management. As such, interest in this subspecialty continues growing internationally. Development of specialized Interventional Neurology training programs, sophisticated neuroendovascular suites, and accredited comprehensive stroke centers help disseminate these advances globally and increase quality stroke care worldwide. Moving forward, new discoveries in telemedicine, robotics, biosimulation and even wearable monitoring promise to transform patient access, precision and recovery from neurological diseases.
Interventional Neurology Market Research Report: By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes, & Others), Product (Aneurysm Coiling & Embolization, Neurothrombectomy, Support Devices, & Others), End User – Global Forecast Till 2027Market HighlightsThe Global interventional neurology market is expected to grow at an approximate CAGR of 7.8% during forecast period, 2018–2023.Increasing participation of market players is the key factor driving the interventional neurology market.
For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.Various other factors such as technological advancements, presence of a large target patient population, favourable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market.However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7211SegmentationThe Global interventional neurology market is segmented based on disease pathology, product, end user and region.The Global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices.
The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems.
The neurothrombectomy devices are further classified as clot retrieval devices, suction and aspiration devices, and snares.
The support devices are further classified as microcatheters, and microguidewires.Based on end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/interventional-neurology-market-7211 Regional AnalysisThe Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.In 2017, it was estimated that Europe stood second in the global interventional neurology market.
Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.On the other hand, the Middle East and Africa held least share in the global interventional neurology market due to the low per capita income, especially within the African region.
Market HighlightsThe Global interventional neurology market is expected to grow at an approximate CAGR of 7.8% during forecast period, 2018–2023.Increasing participation of market players is the key factor driving the interventional neurology market.
For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.Various other factors such as technological advancements, presence of a large target patient population, favourable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market.However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/7211Regional AnalysisThe Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.In 2017, it was estimated that Europe stood second in the global interventional neurology market.
Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region.On the other hand, the Middle East and Africa held least share in the global interventional neurology market due to the low per capita income, especially within the African region.
The burden of neurological disorders in African region has been increasing over the years.
The annual incidence of stroke has been estimated to be 316 per 100 000 in Africa.SegmentationThe Global interventional neurology market is segmented based on disease pathology, product, end user and region.The Global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices.The aneurysm coiling & embolization devices segment is further classified as embolic coils, flow diversion devices, and liquid embolic agents.
The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems.
